Terms: = Leukemia AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
3774 results:
1. Structural studies of intrinsically disordered MLL-fusion protein AF9 in complex with peptidomimetic inhibitors.
Yang Y; Ahmad E; Premkumar V; Liu A; Ashikur Rahman SM; Nikolovska-Coleska Z
Protein Sci; 2024 Jun; 33(6):e5019. PubMed ID: 38747396
[TBL] [Abstract] [Full Text] [Related]
2. [Study on the inhibitory and pro-apoptotic effects of different concentrations of total tanshinone alone and in combination with tyrosine kinase inhibitors on human myeloid leukemia cell lines].
Zhou XS; Fang JC; Ma XL; Zhang Y; Wang F; Chen X; Wu QS; Cao PX; Liu HX
Zhonghua Yi Xue Za Zhi; 2024 May; 104(17):1514-1520. PubMed ID: 38706059
[No Abstract] [Full Text] [Related]
3. Identifying long-term survivors and those at higher or lower risk of relapse among patients with cytogenetically normal acute myeloid leukemia using a high-dimensional mixture cure model.
Archer KJ; Fu H; Mrózek K; Nicolet D; Mims AS; Uy GL; Stock W; Byrd JC; Hiddemann W; Braess J; Spiekermann K; Metzeler KH; Herold T; Eisfeld AK
J Hematol Oncol; 2024 May; 17(1):28. PubMed ID: 38702786
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of LLC0424 as a Potent and Selective
Liu L; Parolia A; Liu Y; Hou C; He T; Qiao Y; Eyunni S; Luo J; Li C; Wang Y; Zhou F; Huang W; Ren X; Wang Z; Chinnaiyan AM; Ding K
J Med Chem; 2024 May; 67(9):6938-6951. PubMed ID: 38687638
[TBL] [Abstract] [Full Text] [Related]
5. Sequence basis of transcription initiation in the human genome.
Dudnyk K; Cai D; Shi C; Xu J; Zhou J
Science; 2024 Apr; 384(6694):eadj0116. PubMed ID: 38662817
[TBL] [Abstract] [Full Text] [Related]
6. [Correlation of
Wang LY; Jiang PF; Li JZ; Chen YX; Hu JD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):395-401. PubMed ID: 38660842
[TBL] [Abstract] [Full Text] [Related]
7. NET-related gene signature for predicting AML prognosis.
Wang J; Wang H; Ding Y; Jiao X; Zhu J; Zhai Z
Sci Rep; 2024 Apr; 14(1):9115. PubMed ID: 38643300
[TBL] [Abstract] [Full Text] [Related]
8. Donor
Schetelig J; Baldauf H; Heidenreich F; Hoogenboom JD; Spellman SR; Kulagin A; Schroeder T; Sengeloev H; Dreger P; Forcade E; Vydra J; Wagner-Drouet EM; Choi G; Paneesha S; Miranda NAA; Tanase A; de Wreede LC; Lange V; Schmidt AH; Sauter J; Fein JA; Bolon YT; He M; Marsh SGE; Gadalla SM; Paczesny S; Ruggeri A; Chabannon C; Fleischhauer K
Front Immunol; 2024; 15():1350470. PubMed ID: 38629074
[TBL] [Abstract] [Full Text] [Related]
9. Methodological challenges in the development of endpoints for myelofibrosis clinical trials.
Barosi G; Tefferi A; Gangat N; Szuber N; Rambaldi A; Odenike O; Kröger N; Gagelmann N; Talpaz M; Kantarjian H; Gale RP
Lancet Haematol; 2024 May; 11(5):e383-e389. PubMed ID: 38604205
[TBL] [Abstract] [Full Text] [Related]
10. Single cell and bulk RNA expression analyses identify enhanced hexosamine biosynthetic pathway and O-GlcNAcylation in acute myeloid leukemia blasts and stem cells.
Schauner R; Cress J; Hong C; Wald D; Ramakrishnan P
Front Immunol; 2024; 15():1327405. PubMed ID: 38601153
[TBL] [Abstract] [Full Text] [Related]
11. Construction and experimental validation of a novel ferroptosis-related gene signature for myelodysplastic syndromes.
Zhu Y; He J; Wei R; Liu J
Immun Inflamm Dis; 2024 Apr; 12(4):e1221. PubMed ID: 38578040
[TBL] [Abstract] [Full Text] [Related]
12. Innovations in conditioning and post-transplant maintenance in AML: genomically informed revelations on the graft-versus-leukemia effect.
Murdock HM; Ho VT; Garcia JS
Front Immunol; 2024; 15():1359113. PubMed ID: 38571944
[TBL] [Abstract] [Full Text] [Related]
13. Proteomics for optimizing therapy in acute myeloid leukemia: venetoclax plus hypomethylating agents versus conventional chemotherapy.
de Camargo Magalhães ES; Hubner SE; Brown BD; Qiu Y; Kornblau SM
Leukemia; 2024 May; 38(5):1046-1056. PubMed ID: 38531950
[TBL] [Abstract] [Full Text] [Related]
14. Gut microbial dysbiosis in the pathogenesis of leukemia: an immune-based perspective.
Goswami M; Bose PD
Exp Hematol; 2024 May; 133():104211. PubMed ID: 38527589
[TBL] [Abstract] [Full Text] [Related]
15. Identification of red blood cell distribution width as a prognostic factor in acute myeloid leukemia.
Liu Q; Zhai Y; Hui Y; Chen J; Mi Y; Wang J; Wei H
Exp Hematol; 2024 May; 133():104206. PubMed ID: 38508299
[TBL] [Abstract] [Full Text] [Related]
16. Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency.
Liongue C; Ratnayake T; Basheer F; Ward AC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474223
[TBL] [Abstract] [Full Text] [Related]
17. Prediction of metabolites associated with somatic mutations in cancers by using genome-scale metabolic models and mutation data.
Lee G; Lee SM; Lee S; Jeong CW; Song H; Lee SY; Yun H; Koh Y; Kim HU
Genome Biol; 2024 Mar; 25(1):66. PubMed ID: 38468344
[TBL] [Abstract] [Full Text] [Related]
18. Uncovering PROTAC Sensitivity and Efficacy by Multidimensional Proteome Profiling: A Case for STAT3.
Suo Y; Du D; Chen C; Zhu H; Wang X; Song N; Lu D; Yang Y; Li J; Wang J; Luo Z; Zhou B; Luo C; Zhou H
J Med Chem; 2024 Mar; 67(6):4804-4818. PubMed ID: 38466231
[TBL] [Abstract] [Full Text] [Related]
19. An ensemble-acute lymphoblastic leukemia model for acute lymphoblastic leukemia image classification.
Huang ML; Huang ZB
Math Biosci Eng; 2024 Jan; 21(2):1959-1978. PubMed ID: 38454670
[TBL] [Abstract] [Full Text] [Related]
20. Assessing Interferon Regulatory Factor 4 Complex Formation: Differential Behavior of Homocomplexes Versus Heterocomplexes Induced by Mutations.
Li Y; Hirano S; Sato K; Osawa M; Nagaoka H
Biochemistry; 2024 Mar; 63(6):767-776. PubMed ID: 38439718
[TBL] [Abstract] [Full Text] [Related]
[Next]
